AMICUS THERAPEUTICS, INC. — Director's Dealing 2019

Jan 10, 2019

SEC Form 4/A — Form 4/A

Issuer: AMICUS THERAPEUTICS, INC. (FOLD)
CIK: 0001178879
Period of Report: 2018-01-03

Reporting Person: Rosenberg Ellen (General Counsel & Corp. Secy)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-01-03	Common Stock	A	27511	$0.00	Acquired	84574	Direct
2018-01-03	Common Stock	F	6112	$15.67	Disposed	78462	Direct

Footnotes

F1: This Form 4 amendment corrects the reporting person's amount of securities beneficially owned following the reported transaction.